The rise in mRNA pharmaceuticals’ licensing agreement values suggests that this field will remain a major area for innovation ...

A large team of microbiologists, pathologists and infectious diseases specialists affiliated with several institutions in the ...

Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...

Moderna doses the first participant in a phase III study evaluating its mRNA norovirus vaccine candidate, mRNA-1403, in the ...

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

The Centers for Disease Control and Prevention (CDC) currently recommends that everyone aged 6 months and up get the Moderna or Pfizer COVID-19 vaccines. The Novavax vaccine is authorized by the U.S.

The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health ...

Most investors unaware of the huge breakthroughs happening in biotech right now. But new technologies such as cancer-killing ...

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage III or IV non-small cell lung cancer.

A pair of American scientists have won the 2024 Nobel Prize in medicine for their discovery of microRNA, tiny genetic ...

We recently compiled a list of 10 Worst Performing Stocks to Buy on the Dip. In this article, we will look at where Moderna, ...

The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health ...